{"id":23081,"date":"2023-07-19T13:26:23","date_gmt":"2023-07-19T20:26:23","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23081"},"modified":"2026-04-07T10:39:51","modified_gmt":"2026-04-07T17:39:51","slug":"exploring-ivig-therapy-for-guillain-barre-syndrome","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/","title":{"rendered":"\u00bfPuede la inmunoglobulina intravenosa (IVIG) tratar el s\u00edndrome de Guillain-Barr\u00e9? Todo lo que necesitas saber."},"content":{"rendered":"<p>El s\u00edndrome de Guillain-Barr\u00e9 es una enfermedad autoinmune poco com\u00fan pero grave. Afecta los nervios y, en ocasiones, puede ser mortal. Aunque no existe cura conocida, existen tratamientos como la inmunoglobulina intravenosa (IVIG) para el s\u00edndrome de Guillain-Barr\u00e9.<\/p>\n\n\n\n<p>Las personas pueden recuperarse completamente con un tratamiento temprano. Si padece esta enfermedad, tambi\u00e9n podr\u00eda beneficiarse del tratamiento con IgIV. Aqu\u00ed encontrar\u00e1 todo lo que necesita saber sobre la IgIV para el s\u00edndrome de Guillain-Barr\u00e9.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#What_is_Guillain-Barre_Syndrome\" >\u00bfQu\u00e9 es el s\u00edndrome de Guillain-Barr\u00e9?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#Symptoms\" >S\u00edntomas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#GBS_Subtypes\" >Subtipos de SGB<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#Causes\" >Causas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#Diagnosis\" >Diagn\u00f3stico<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#Treatments\" >Tratos<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#IVIG_for_GBS\" >IgIV para el s\u00edndrome de Guillain-Barr\u00e9<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#Is_IVIG_Truly_Effective_for_Guillain-Barre_Syndrome\" >\u00bfEs la IgIV realmente efectiva para el s\u00edndrome de Guillain-Barr\u00e9?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#An_Assessment_of_IVIG_as_Therapy_for_Pediatric_GBS\" >Una evaluaci\u00f3n de la IgIV como terapia para el s\u00edndrome de Guillain-Barr\u00e9 pedi\u00e1trico<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#A_Meta-Analysis_of_Treatment_Efficiencies_for_Guillain-Barre_Syndrome\" >Un metaan\u00e1lisis de la eficacia del tratamiento del s\u00edndrome de Guillain-Barr\u00e9<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#A_Review_of_the_Effects_of_IVIG_on_Guillain-Barre\" >Una revisi\u00f3n de los efectos de la IgIV en el s\u00edndrome de Guillain-Barr\u00e9<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#An_Assessment_of_Mobility_After_Treating_Guillain-Barre_With_IVIG\" >Evaluaci\u00f3n de la movilidad tras el tratamiento del s\u00edndrome de Guillain-Barr\u00e9 con IgIV<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#IVIG_Procedure_for_Guillain-Barre\" >Procedimiento de IgIV para el s\u00edndrome de Guillain-Barr\u00e9<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#Side_Effects_of_IVIG_Treatment_for_Guillain-Barre_Syndrome\" >Efectos secundarios del tratamiento con IgIV para el s\u00edndrome de Guillain-Barr\u00e9<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#When_Will_I_See_the_Results\" >\u00bfCuando ver\u00e9 los resultados?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#Cost_of_IVIG_Treatment_for_Guillain-Barre_Syndrome\" >Costo del tratamiento con IgIV para el s\u00edndrome de Guillain-Barr\u00e9<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#Receive_At-Home_IVIG_Treatment_for_Guillain-Barre_Syndrome_from_AmeriPharma%C2%AE_Specialty_Pharmacy\" >Reciba tratamiento con IgIV en casa para el s\u00edndrome de Guillain-Barr\u00e9 en la farmacia especializada AmeriPharma\u00ae<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-guillain-barre-syndrome\"><span class=\"ez-toc-section\" id=\"What_is_Guillain-Barre_Syndrome\"><\/span>\u00bfQu\u00e9 es el s\u00edndrome de Guillain-Barr\u00e9?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Antes de aprender sobre la IgIV, debes comprender <a href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/gbs-guillain-barre-syndrome\/\">\u00bfQu\u00e9 es el s\u00edndrome de Guillain-Barr\u00e9?<\/a>El s\u00edndrome de Guillain-Barr\u00e9 (SGB) es un trastorno autoinmune grave de aparici\u00f3n r\u00e1pida.<\/p>\n\n\n\n<p>En esta enfermedad, el sistema inmunitario ataca el sistema nervioso perif\u00e9rico, lo que progresa r\u00e1pidamente a debilidad y par\u00e1lisis de las extremidades. El s\u00edndrome de Guillain-Barr\u00e9 puede afectar a personas de todas las edades. Sin embargo, es m\u00e1s com\u00fan en hombres adultos.<\/p>\n\n\n\n<p>En los Estados Unidos, <a href=\"https:\/\/www.medscape.com\/answers\/315632-14154\/what-is-the-incidence-of-guillain-barre-syndrome-gbs-in-the-us\">dos de cada 100.000 personas<\/a> Sufren de s\u00edndrome de Guillain-Barr\u00e9, que puede tratarse con inmunoglobulina intravenosa (IVIG). Quienes no reciben tratamiento, especialmente las personas mayores, pueden requerir hospitalizaci\u00f3n.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-symptoms\"><span class=\"ez-toc-section\" id=\"Symptoms\"><\/span>S\u00edntomas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>El s\u00edndrome de Guillain-Barr\u00e9 afecta los brazos y las piernas, y la mayor\u00eda de los pacientes presentan signos de infecci\u00f3n viral semanas antes del diagn\u00f3stico. El m\u00e1s com\u00fan <a href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-symptoms\/\">s\u00edntomas del s\u00edndrome de Guillain-Barr\u00e9<\/a> incluir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Visi\u00f3n borrosa<\/li>\n\n\n\n<li>debilidad muscular<\/li>\n\n\n\n<li>Dificultades respiratorias<\/li>\n\n\n\n<li>Problemas de equilibrio y coordinaci\u00f3n<\/li>\n\n\n\n<li>Dificultades para masticar y tragar<\/li>\n\n\n\n<li>Hormigueo y entumecimiento en las manos y los pies.<\/li>\n<\/ul>\n\n\n\n<p>Estos s\u00edntomas pueden empeorar r\u00e1pidamente, debilitar los m\u00fasculos del sistema respiratorio y causar par\u00e1lisis completa. Si no recibe IgIV para el s\u00edndrome de Guillain-Barr\u00e9, podr\u00eda terminar en urgencias y requerir ventilaci\u00f3n asistida.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-gbs-subtypes\"><span class=\"ez-toc-section\" id=\"GBS_Subtypes\"><\/span>Subtipos de SGB<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Existen varios subtipos de s\u00edndrome de Guillain-Barr\u00e9 para los que la IgIV puede ser beneficiosa. Estos subtipos incluyen:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-acute-inflammatory-demyelinating-polyneuropathy-aidp\">Polineuropat\u00eda desmielinizante inflamatoria aguda (AIDP)<\/h4>\n\n\n\n<p>Este subtipo representa hasta el 80% de los casos y es m\u00e1s com\u00fan en Europa y Norteam\u00e9rica. Comienza con debilidad muscular en la parte inferior del cuerpo.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-acute-motor-axonal-neuropathy-aman\"><a href=\"https:\/\/www.medlink.com\/articles\/acute-motor-axonal-neuropathy\">Neuropat\u00eda axonal motora aguda<\/a> (AMAN)<\/h4>\n\n\n\n<p>Este subtipo es m\u00e1s frecuente en M\u00e9xico, Jap\u00f3n y China. No se asocia con s\u00edntomas sensoriales.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-acute-motor-sensory-axonal-neuropathy-amsan\">Neuropat\u00eda axonal sensitivo-motora aguda (AMSAN)<\/h4>\n\n\n\n<p>Este subtipo es una de las formas m\u00e1s graves del SGB y requiere asistencia respiratoria prolongada. La AMSAN tambi\u00e9n es m\u00e1s com\u00fan en M\u00e9xico, Jap\u00f3n y China.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-miller-fisher-syndrome-mf\"><a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/what-is-miller-fisher-syndrome\/\">S\u00edndrome de Miller-Fisher (MF)<\/a><\/h4>\n\n\n\n<p>Este subtipo es m\u00e1s frecuente en pa\u00edses del este asi\u00e1tico, como Jap\u00f3n y Taiw\u00e1n. Provoca visi\u00f3n doble, problemas de equilibrio y reflejos tendinosos profundos.<\/p>\n\n\n\n<p>La dosis de IgIV para cada subtipo de s\u00edndrome de Guillain-Barr\u00e9 puede variar.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-causes\"><span class=\"ez-toc-section\" id=\"Causes\"><\/span>Causas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Los cient\u00edficos a\u00fan no han determinado con exactitud <a href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/what-causes-guillain-barre-syndrome\/\">causa del s\u00edndrome de Guillain-Barr\u00e9<\/a>Sin embargo, las siguientes condiciones pueden desencadenar el SGB:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>C\u00e1ncer<\/li>\n\n\n\n<li>Trauma<\/li>\n\n\n\n<li>Cirug\u00eda<\/li>\n\n\n\n<li>Vacunaci\u00f3n<\/li>\n\n\n\n<li>Infecciones virales<\/li>\n\n\n\n<li>Infecciones bacterianas<\/li>\n<\/ul>\n\n\n\n<p>Estos factores pueden desencadenar una respuesta inmune en el cuerpo y hacer que el sistema inmunol\u00f3gico ataque sus propios nervios sanos.<\/p>\n\n\n\n<p>Este ataque da\u00f1a la vaina de mielina que rodea los nervios y provoca debilidad muscular. El uso de IgIV para el s\u00edndrome de Guillain-Barr\u00e9 busca regular esta respuesta inmunitaria.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-diagnosis\"><span class=\"ez-toc-section\" id=\"Diagnosis\"><\/span>Diagn\u00f3stico<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Para determinar si tiene SGB, un m\u00e9dico evaluar\u00e1 su historial m\u00e9dico y le realizar\u00e1 un examen f\u00edsico. Luego, le recomendar\u00e1 las siguientes pruebas: <a href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/how-is-guillain-barre-syndrome-diagnosed\/\">diagnosticar el s\u00edndrome de Guillain-Barr\u00e9<\/a>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Pruebas nerviosas<\/li>\n\n\n\n<li>Pruebas de anticuerpos<\/li>\n\n\n\n<li>Estudios de conducci\u00f3n nerviosa<\/li>\n\n\n\n<li>An\u00e1lisis del l\u00edquido cefalorraqu\u00eddeo (LCR)<\/li>\n<\/ul>\n\n\n\n<p>Con un diagn\u00f3stico temprano de la enfermedad se pueden controlar mejor los s\u00edntomas y acortar el tratamiento.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-treatments\"><span class=\"ez-toc-section\" id=\"Treatments\"><\/span>Tratos<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Hay varios <a href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-treatment-options\/\">Opciones de tratamiento para el s\u00edndrome de Guillain-Barr\u00e9<\/a>Estos son los dos tratamientos principales.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-plasma-exchange-plasmapheresis\">Intercambio de plasma (plasmaf\u00e9resis)<\/h4>\n\n\n\n<p>En este tratamiento alternativo a la IgIV para el s\u00edndrome de Guillain-Barr\u00e9, una m\u00e1quina extrae su sangre, la filtra para eliminar los anticuerpos da\u00f1inos y la devuelve a su cuerpo.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-ivig\">IgIV<\/h4>\n\n\n\n<p>El tratamiento m\u00e1s com\u00fan para el s\u00edndrome de Guillain-Barr\u00e9 es la terapia con IgIV o inmunoglobulina intravenosa.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ivig-for-gbs\"><span class=\"ez-toc-section\" id=\"IVIG_for_GBS\"><\/span>IgIV para el s\u00edndrome de Guillain-Barr\u00e9<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-1024x682.jpg\" alt=\"Patient with an IV line\" class=\"wp-image-23250\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-1024x682.jpg 1024w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-768x512.jpg 768w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-370x247.jpg 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1-960x640.jpg 960w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-patient-iv-line-1.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p><\/p>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/immune-globulin-injection\/\">inyecciones de inmunoglobulina<\/a> Son soluciones que contienen plasma de sangre donada que contiene anticuerpos sanos. Si bien el mecanismo de acci\u00f3n exacto de la IgIV a\u00fan no est\u00e1 bien establecido, los cient\u00edficos sugieren que estos anticuerpos sanos modulan un sistema inmunitario debilitado.<\/p>\n\n\n\n<p>Controlan el sistema inmunitario al reducir los anticuerpos da\u00f1inos que atacan los nervios. Estas infusiones reducir\u00e1n la gravedad de los s\u00edntomas y aliviar\u00e1n el da\u00f1o nervioso. Sin embargo, la IgIV no cura el s\u00edndrome de Guillain-Barr\u00e9.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-is-ivig-truly-effective-for-guillain-barre-syndrome\"><span class=\"ez-toc-section\" id=\"Is_IVIG_Truly_Effective_for_Guillain-Barre_Syndrome\"><\/span>\u00bfEs la IgIV realmente efectiva para el s\u00edndrome de Guillain-Barr\u00e9?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>S\u00ed. La IgIV es una potente opci\u00f3n de tratamiento para el s\u00edndrome de Guillain-Barr\u00e9. Numerosos estudios confirman su eficacia. Analicemos algunos de ellos con m\u00e1s detalle.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-an-assessment-of-ivig-as-therapy-for-pediatric-gbs\"><span class=\"ez-toc-section\" id=\"An_Assessment_of_IVIG_as_Therapy_for_Pediatric_GBS\"><\/span>Una evaluaci\u00f3n de la IgIV como terapia para el s\u00edndrome de Guillain-Barr\u00e9 pedi\u00e1trico<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Un temprano <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9309521\/\">estudio en 1997<\/a> Se evalu\u00f3 la eficacia de la IgIV en el SGB pedi\u00e1trico. En esta investigaci\u00f3n, los cient\u00edficos trataron a siete ni\u00f1os con una mediana de edad de 5,8 a\u00f1os con una infusi\u00f3n de IgIV de 0,4 g\/kg\/d\u00eda durante 5 d\u00edas.<\/p>\n\n\n\n<p>Observaron mejoras cl\u00ednicas entre uno y dos d\u00edas despu\u00e9s del tratamiento. Su revisi\u00f3n de otros estudios revel\u00f3 que 74 ni\u00f1os m\u00e1s experimentaron mejoras en sus s\u00edntomas tras recibir IgIV para la enfermedad de Guillain-Barr\u00e9.<\/p>\n\n\n\n<p>Concluyeron que la IgIV era tan efectiva como la plasmaf\u00e9resis con menos complicaciones y deber\u00eda ser la terapia de primera l\u00ednea para el s\u00edndrome de Guillain-Barr\u00e9.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-a-meta-analysis-of-treatment-efficiencies-for-guillain-barre-syndrome\"><span class=\"ez-toc-section\" id=\"A_Meta-Analysis_of_Treatment_Efficiencies_for_Guillain-Barre_Syndrome\"><\/span>Un metaan\u00e1lisis de la eficacia del tratamiento del s\u00edndrome de Guillain-Barr\u00e9<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Una m\u00e1s reciente <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8519256\/\">estudiar en 2021<\/a> Compararon la eficacia de diferentes tratamientos para el SGB. Para este an\u00e1lisis, los investigadores analizaron 28 ensayos cl\u00ednicos con 2474 sujetos y grupos de control humanos.<\/p>\n\n\n\n<p>Descubrieron que los corticosteroides no tuvieron un efecto significativo, mientras que la inmunoglobulina intravenosa (IVIG) y la plasmaf\u00e9resis fueron eficaces para el tratamiento del SGB. Sugirieron que en futuros ensayos se deber\u00eda explorar m\u00e1s a fondo la eficacia de las terapias combinadas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-a-review-of-the-effects-of-ivig-on-guillain-barre\"><span class=\"ez-toc-section\" id=\"A_Review_of_the_Effects_of_IVIG_on_Guillain-Barre\"><\/span>Una revisi\u00f3n de los efectos de la IgIV en el s\u00edndrome de Guillain-Barr\u00e9<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>En otro <a href=\"https:\/\/www.pharmacytimes.com\/view\/study-intravenous-immunoglobulin-hastens-recovery-of-early-onset-guillain-barre\">revisi\u00f3n en 2021<\/a>Los cient\u00edficos analizaron 12 ensayos cl\u00ednicos. Descubrieron que, incluso en los casos m\u00e1s graves del s\u00edndrome de Guillain-Barr\u00e9, la IgIV puede acelerar la recuperaci\u00f3n si se administra dentro de las dos semanas posteriores al inicio de la enfermedad.<\/p>\n\n\n\n<p>Seg\u00fan su investigaci\u00f3n, el 251% de los casos de SGB son lo suficientemente graves como para requerir ventilaci\u00f3n artificial, y entre el 31% y el 121% de los pacientes fallecen por complicaciones. Su hallazgo demuestra que la IgIV puede ayudar a acelerar la recuperaci\u00f3n de estos pacientes y a mejorar sus s\u00edntomas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-an-assessment-of-mobility-after-treating-guillain-barre-with-ivig\"><span class=\"ez-toc-section\" id=\"An_Assessment_of_Mobility_After_Treating_Guillain-Barre_With_IVIG\"><\/span>Evaluaci\u00f3n de la movilidad tras el tratamiento del s\u00edndrome de Guillain-Barr\u00e9 con IgIV<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>En uno de los \u00faltimos <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S204908012201576X\">estudios observacionales en diciembre de 2022<\/a>Los cient\u00edficos examinaron a pacientes con SGB tratados con IgIV.<\/p>\n\n\n\n<p>Midieron la probabilidad promedio predicha de no poder caminar sin ayuda despu\u00e9s de recibir el tratamiento. Sus hallazgos fueron los siguientes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>47.7% despu\u00e9s de 4 semanas<\/li>\n\n\n\n<li>17% despu\u00e9s de 3 meses<\/li>\n\n\n\n<li>8.05% despu\u00e9s de 6 meses<\/li>\n<\/ul>\n\n\n\n<p>Concluyeron que la detecci\u00f3n temprana del s\u00edndrome de Guillain-Barr\u00e9 y el tratamiento con IgIV mejoran la movilidad, medida mediante la Escala de resultados Erasmus GBS modificada.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ivig-procedure-for-guillain-barre\"><span class=\"ez-toc-section\" id=\"IVIG_Procedure_for_Guillain-Barre\"><\/span>Procedimiento de IgIV para el s\u00edndrome de Guillain-Barr\u00e9<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Recibir infusiones de IgIV para el SGB es sencillo y pr\u00e1cticamente indoloro. El tratamiento puede administrarse por v\u00eda intravenosa o subcut\u00e1nea. Sentir\u00e1 un dolor leve solo cuando la enfermera le inserte la aguja en el brazo.<\/p>\n\n\n\n<p>Puedes optar por <a href=\"https:\/\/ameripharmaspecialty.com\/es\/home-infusion\/\">servicios de infusi\u00f3n a domicilio<\/a>Visite un centro de infusi\u00f3n o acuda a un hospital para recibir su tratamiento. Cada infusi\u00f3n tardar\u00e1 entre 3 y 5 horas. Recibir\u00e1 2 g de IgIV por kg de peso corporal, repartidos en 5 d\u00edas.<\/p>\n\n\n\n<p>Si necesita una segunda dosis, puede recibirla entre 7 y 9 d\u00edas despu\u00e9s de la primera. La inmunoglobulina intravenosa (IVIG) para el s\u00edndrome de Guillain-Barr\u00e9 solo se administra bajo la supervisi\u00f3n de un m\u00e9dico.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-side-effects-of-ivig-treatment-for-guillain-barre-syndrome\"><span class=\"ez-toc-section\" id=\"Side_Effects_of_IVIG_Treatment_for_Guillain-Barre_Syndrome\"><\/span>Efectos secundarios del tratamiento con IgIV para el s\u00edndrome de Guillain-Barr\u00e9<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-1024x682.jpg\" alt=\"A woman with a headache\" class=\"wp-image-23251\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-1024x682.jpg 1024w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-768x512.jpg 768w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-370x247.jpg 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1-960x640.jpg 960w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-guillain-barre-woman-headache-1.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p><\/p>\n\n\n\n<p>El tratamiento con IgIV para el SGB puede provocar efectos secundarios inmediatos o retardados en algunas personas. Los efectos secundarios inmediatos incluyen dolor de cabeza leve, escalofr\u00edos, fiebre y dolores corporales que remiten en breve.<\/p>\n\n\n\n<p>Los efectos secundarios tard\u00edos de la IgIV son poco frecuentes y pueden incluir insuficiencia renal, problemas neurol\u00f3gicos y eventos tromb\u00f3ticos. Cabe destacar que menos del 1% de los receptores de IgIV experimentan estos efectos secundarios.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-when-will-i-see-the-results\"><span class=\"ez-toc-section\" id=\"When_Will_I_See_the_Results\"><\/span>\u00bfCuando ver\u00e9 los resultados?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Las expectativas del tratamiento con IgIV para el s\u00edndrome de Guillain-Barr\u00e9 variar\u00e1n seg\u00fan la gravedad de los s\u00edntomas. La mejor\u00eda tardar\u00e1 un tiempo en notarse.<\/p>\n\n\n\n<p>La mayor\u00eda de las personas notan alivio de sus s\u00edntomas despu\u00e9s de 6 a 12 meses. Para otras, puede tardar hasta 3 a\u00f1os. Algunos s\u00edntomas pueden persistir incluso despu\u00e9s del tratamiento. Sin embargo, algunas personas se han recuperado completamente con el tratamiento.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cost-of-ivig-treatment-for-guillain-barre-syndrome\"><span class=\"ez-toc-section\" id=\"Cost_of_IVIG_Treatment_for_Guillain-Barre_Syndrome\"><\/span>Costo del tratamiento con IgIV para el s\u00edndrome de Guillain-Barr\u00e9<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La IgIV es un tratamiento costoso debido a su proceso de fabricaci\u00f3n. El costo por gramo puede variar entre $100 y $350. Este precio var\u00eda seg\u00fan la edad, el peso, el n\u00famero de infusiones necesarias, el m\u00e9todo de inyecci\u00f3n, etc.<\/p>\n\n\n\n<p>El conjunto <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/cost-of-ivig-treatment\/\">costo de la IgIV<\/a> El tratamiento del s\u00edndrome de Guillain-Barr\u00e9 puede costar m\u00e1s de 1,447 a 5,000 d\u00f3lares. Sin embargo, existen opciones de asistencia financiera para ayudar a reducir el costo de sus tratamientos.<\/p>\n\n\n\n<p>La mayor\u00eda de los planes de seguro cubren una parte de los costos y usted puede solicitar <a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">programas de asistencia para copagos<\/a> Dise\u00f1ado para ayudar a las personas que luchan contra el SGB. Nuestros expertos en la Farmacia Especializada AmeriPharma\u00ae pueden ayudarle a encontrar los mejores programas para su afecci\u00f3n.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-receive-at-home-ivig-treatment-for-guillain-barre-syndrome-from-ameripharma-specialty-pharmacy\"><span class=\"ez-toc-section\" id=\"Receive_At-Home_IVIG_Treatment_for_Guillain-Barre_Syndrome_from_AmeriPharma%C2%AE_Specialty_Pharmacy\"><\/span>Reciba tratamiento con IgIV en casa para el s\u00edndrome de Guillain-Barr\u00e9 en la farmacia especializada AmeriPharma\u00ae<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El s\u00edndrome de Guillain-Barr\u00e9 puede ser una afecci\u00f3n potencialmente mortal. Sin embargo, se puede controlar con detecci\u00f3n y tratamiento tempranos. La Farmacia Especializada AmeriPharma\u00ae est\u00e1 aqu\u00ed para ayudarle.<\/p>\n\n\n\n<p>Nuestra farmacia de servicio completo ofrece servicios de infusi\u00f3n a domicilio y tratamientos con IgIV para la enfermedad de Guillain-Barr\u00e9. Podemos enviar una enfermera titulada a su domicilio a la hora que usted elija para administrarle el tratamiento.<\/p>\n\n\n\n<p>Con asistencia para copagos, asistencia las 24 horas, los 7 d\u00edas de la semana, los 365 d\u00edas del a\u00f1o y servicios en m\u00e1s de 40 estados y territorios de EE. UU., estamos aqu\u00ed para ayudarlo a controlar su afecci\u00f3n.<\/p>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/get-started\/\">Cont\u00e1ctanos hoy<\/a> Para hablar con un especialista y comenzar a recibir atenci\u00f3n especializada en casa. Visite nuestro <a href=\"https:\/\/ameripharmaspecialty.com\/es\/blog\/\">blog<\/a> para obtener m\u00e1s informaci\u00f3n sobre nuestras infusiones de IgIV y otros tratamientos para <a href=\"https:\/\/ameripharmaspecialty.com\/es\/conditions-treatments\/\">condiciones de salud complejas<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>El s\u00edndrome de Guillain-Barr\u00e9 es una enfermedad autoinmune poco com\u00fan pero grave. Afecta los nervios y, en ocasiones, puede ser mortal. Aunque no existe cura conocida, existen tratamientos como la inmunoglobulina intravenosa (IVIG) para el s\u00edndrome de Guillain-Barr\u00e9.<\/p>","protected":false},"author":7,"featured_media":23082,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[8],"class_list":["post-23081","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG Therapy for Guillain-Barre: What to Expect | AmeriPharma<\/title>\n<meta name=\"description\" content=\"Are you considering IVIG therapy for Guillain-Barre syndrome? Learn everything you need to know about IVIG for GBS in this guide from AmeriPharma\u2122 Specialty.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG Therapy for Guillain-Barre: What to Expect | AmeriPharma\" \/>\n<meta property=\"og:description\" content=\"Are you considering IVIG therapy for Guillain-Barre syndrome? Learn everything you need to know about IVIG for GBS in this guide from AmeriPharma\u2122 Specialty.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-19T20:26:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-07T17:39:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1442\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"Can IVIG Treat Guillain-Barre Syndrome? Everything You Need To Know\",\"datePublished\":\"2023-07-19T20:26:23+00:00\",\"dateModified\":\"2026-04-07T17:39:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/\"},\"wordCount\":1483,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/\",\"name\":\"IVIG Therapy for Guillain-Barre: What to Expect | AmeriPharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg\",\"datePublished\":\"2023-07-19T20:26:23+00:00\",\"dateModified\":\"2026-04-07T17:39:51+00:00\",\"description\":\"Are you considering IVIG therapy for Guillain-Barre syndrome? Learn everything you need to know about IVIG for GBS in this guide from AmeriPharma\u2122 Specialty.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg\",\"width\":2560,\"height\":1442,\"caption\":\"A person with Guillain-Barre syndrome holding her hand in pain\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/ivig\\\/exploring-ivig-therapy-for-guillain-barre-syndrome\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Can IVIG Treat Guillain-Barre Syndrome? Everything You Need To Know\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IVIG Therapy for Guillain-Barre: What to Expect | AmeriPharma","description":"Are you considering IVIG therapy for Guillain-Barre syndrome? Learn everything you need to know about IVIG for GBS in this guide from AmeriPharma\u2122 Specialty.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG Therapy for Guillain-Barre: What to Expect | AmeriPharma","og_description":"Are you considering IVIG therapy for Guillain-Barre syndrome? Learn everything you need to know about IVIG for GBS in this guide from AmeriPharma\u2122 Specialty.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-07-19T20:26:23+00:00","article_modified_time":"2026-04-07T17:39:51+00:00","og_image":[{"width":2560,"height":1442,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"Can IVIG Treat Guillain-Barre Syndrome? Everything You Need To Know","datePublished":"2023-07-19T20:26:23+00:00","dateModified":"2026-04-07T17:39:51+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/"},"wordCount":1483,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/","name":"IVIG Therapy for Guillain-Barre: What to Expect | AmeriPharma","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg","datePublished":"2023-07-19T20:26:23+00:00","dateModified":"2026-04-07T17:39:51+00:00","description":"Are you considering IVIG therapy for Guillain-Barre syndrome? Learn everything you need to know about IVIG for GBS in this guide from AmeriPharma\u2122 Specialty.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg","width":2560,"height":1442,"caption":"A person with Guillain-Barre syndrome holding her hand in pain"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/exploring-ivig-therapy-for-guillain-barre-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Can IVIG Treat Guillain-Barre Syndrome? Everything You Need To Know"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg",2560,1442,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-300x169.jpg",300,169,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-768x433.jpg",768,433,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-1024x577.jpg",1024,577,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-1536x865.jpg",1536,865,true],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-2048x1154.jpg",2048,1154,true],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg",18,10,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg",600,338,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-86x48.jpg",86,48,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-167x94.jpg",167,94,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-280x158.jpg",280,158,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-370x208.jpg",370,208,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-960x541.jpg",960,541,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-1280x721.jpg",1280,721,true]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Guillain-Barre is a rare but serious autoimmune condition. It affects the nerves and can sometimes be life-threatening. While no known cure exists, treatments such as IVIG are available for Guillain-Barre disease.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg",2560,1442,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg",2560,1442,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg",2560,1442,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-300x169.jpg",300,169,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-1024x577.jpg",1024,577,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-1536x865.jpg",1536,865,true],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-2048x1154.jpg",2048,1154,true],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg",18,10,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1.jpg",600,338,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-86x48.jpg",86,48,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-167x94.jpg",167,94,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-280x158.jpg",280,158,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-370x208.jpg",370,208,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-960x541.jpg",960,541,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Guillain-Barre-syndrome-IVIG-hand-pain-scaled-1-1280x721.jpg",1280,721,true]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Guillain-Barre is a rare but serious autoimmune condition. It affects the nerves and can sometimes be life-threatening. While no known cure exists, treatments such as IVIG are available for Guillain-Barre disease.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=23081"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23081\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/23082"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=23081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=23081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=23081"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}